Abouelmagd A (Ahmed Aboelmagd)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

Postoperative Pain

Endoplasmic Reticulum Stress

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Abbas M Abbas, Hossam H Nasrallah, Abouelmagd A, Safaa M Kishk, Warren Christopher Boyd, Haitham Kalil, Adel S Orabi
Design, Synthesis, Anti-Inflammatory Activity, DFT Modeling and Docking Study of New Ibuprofen Derivatives. International journal of molecular sciences 25 (6) (2024)
Abbas M Abbas, Hossam H Nasrallah, Abouelmagd A, Safaa M Kishk, Warren Christopher Boyd, Haitham Kalil, Adel S Orabi
Design, Synthesis, Anti-Inflammatory Activity, DFT Modeling and Docking Study of New Ibuprofen Derivatives. International journal of molecular sciences 25 (6) (2024)
Abbas M Abbas, Hossam H Nasrallah, Abouelmagd A, Safaa M Kishk, Warren Christopher Boyd, Haitham Kalil, Adel S Orabi
Design, Synthesis, Anti-Inflammatory Activity, DFT Modeling and Docking Study of New Ibuprofen Derivatives. International journal of molecular sciences 25 (6) (2024)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Samir Mohamed El Rayes, Abouelmagd A, Mohamed S Gomaa, Walid Fathalla, Ibrahim A I Ali, Faheem H Pottoo, Sarah Mousa Asiri
Newly synthesized 3-(4-chloro-phenyl)-3-hydroxy-2,2-dimethyl-propionic acid methyl ester derivatives selectively inhibit the proliferation of colon cancer cells. RSC advances 10 (15) (2020)
Samir Mohamed El Rayes, Gomaa M S, Abouelmagd A, Walid Fathalla, Ibrahim A I Ali
Synthesis and antiproliferative assay of triazolyl-2,2-dimethyl-3-phenylpropanoates as potential HDAC inhibitors. RSC advances 9 (24) (2019)